Sunday, November 22, 2026 · The Health Policy Podcast
Health Policy Podcast logo

Receive new episodes in your inbox.

Center for Medicine in the Public Interest logo

Organization

Center for Medicine in the Public Interest

880 3rd Ave 5th Floor New York, NY 10022

The Center for Medicine in the Public Interest (CMPI) is a nonprofit, nonpartisan research and educational organization dedicated to advancing patient-centered healthcare. Through research, policy analysis, and public education, CMPI promotes medical innovation, improved access to treatment, and more affordable healthcare. Its work addresses drug safety, personalized medicine, healthcare reform, and the value of medical progress.

Coverage areas

Guests (1)

Episodes (1)

  • 2026-10-08

    The Preventable Peptide Crisis: Navigating GLP-1s and the Gray Market

    with Peter Pitts

    The rising popularity of GLP-1 medications for weight loss has been accompanied by dangers in the gray market, including counterfeit and unapproved drugs, says Peter Pitts, president of the Center for Medicine in the Public Interest, in a Health Policy Podcast interview with Bryan Hyde. Pitts discusses the health implications of using these drugs without medical supervision and the risks associated with counterfeit and unapproved medications. He emphasizes the importance of FDA oversight and urges consumers to consult healthcare professionals before seeking weight loss solutions online.

Notable quotes

  • “Being the proper weight is a really important thing to make sure we live longer, healthier lives.”
  • “GLP-1s are indicated to be used in combination with diet and exercise.”
  • “The most important consequence is unintended, very negative health consequences for the people that are trying to circumvent the system.”
  • “Buyer beware. Caveat emptor, you know, is bad pharmaceutical policy.”
  • “Sometimes a bargain is just too expensive, as my grandmother used to say.”
  • “If something looks too good to be true, a big red flag should go up.”